22nw, LP
22NW, LP is a Seattle-based hedge fund and investment adviser founded in 2015, with approximately 6 employees. The firm manages pooled investment vehicles primarily for US institutional and accredited investors and reports regulatory filings with the SEC. 22NW’s investment team focuses on fundamental-driven, concentrated equity strategies.
Investment Strategy
22NW, LP employs a concentrated, fundamental value-focused equity strategy. It seeks investment opportunities across industries, concentrating capital in its best ideas based on extensive research and analysis. The firm often takes activist positions in small- and mid-cap companies, aiming to unlock shareholder value through operational improvements, strategic changes, and board engagement. 22NW manages discretionary portfolios and follows a long-term investment philosophy, targeting compelling risk/reward profiles.
Latest 13F Filing Activity
22nw, LP filed their most recent 13F report on Jun 30, 2025 disclosing 19 equity positions with a total 13F market value of $159M. The fund increased holdings in Stoneridge Inc., Dhi Group Inc., Meiragtx HLDGS PLC among other positions. 22nw, LP reduced exposure to Sterling Infrastructure Inc., Lifecore Biomedical Inc., Barrett Business SVCS Inc. among others.
Top Holdings
Equity Positions (19)
| Ticker | Security | Weight | Market Value | Shares | Avg Cost | Price | Change (QoQ) |
|---|---|---|---|---|---|---|---|
F FSTR | FOSTER L B CO | 18.08% | $28.7M | 1,313,121 | $15.00 | $21.87 | +$2.9M |
L LFCR | LIFECORE BIOMEDICAL INC | 14.25% | $22.6M | 264,180 | $10.23 | $8.12 | -$7.2M |
A ANEB | ANEBULO PHARMACEUTICALS INC | 14.03% | $22.3M | 15,467,300 | $2.93 | $1.44 | +$2.2M |
S SRI | STONERIDGE INC | 8.62% | $13.7M | 1,943,508 | $5.28 | $7.04 | +$6.2M |
D DHX | DHI GROUP INC | 6.17% | $9.8M | 3,299,937 | $2.36 | $2.97 | +$6.2M |